PBS blog features stories looking at mobile technology and health in Africa

NewsGuard 100/100 Score

PBS's "Rundown" blog features two stories as part of the "Cheers Report," a "series of reports on the impact of mobile technology and health in 10 African countries." In the first story, Imani Cheers, the director of educational resources and a multimedia producer for the PBS NewsHour, describes how mobile phones are helping to fight malaria in Zambia, where community health workers receive cell phones in return for their rapid reporting of malaria cases (4/25). The second story describes how "the Malawi Ministry of Health and [non-governmental organizations (NGOs)] such as Village Reach are collaborating with communities to use cell phones to address some of the causes of poor health care for women and children," such as "limited availability of timely and reliable health information, access and use of health facilities and delays in services," Cheers reports (4/26).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

  1. Shumaila Satti Shumaila Satti Islamic Republic of Pakistan says:

    good post, this post is very informative, thanks for this post

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Navigating the complexities of controlled release drug formulations